ArticleObesity science & practice2017
Treatment with liraglutide may improve markers of CVD reflected by reduced levels of apoB.
L Engelbrechtsen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
21 papers cite it
this papertrialcites it